Patent directory · USPTO A61K / A61P
Patents matching “BIOMARIN PHARMACEUTICAL INC.”
112 pharma patents match "BIOMARIN PHARMACEUTICAL INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 112 pharmaceutical patents matching "BIOMARIN PHARMACEUTICAL INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12239692
Adeno-associated virus factor VIII vectors
granted -
US 12233106
C-type natriuretic peptide variants to treat skeletal dysplasia in children
granted -
US 12214015
Use of c-type natriuretic peptide variants to treat osteoarthritis
granted -
US 12188058
Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof
granted -
US 12076372
Use of C-type natriuretic peptide variants to treat skeletal dysplasia
granted -
US 11918633
Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating adolescent subjects
granted -
US 11911446
Use of C-type natriuretic peptide variants to treat skeletal dysplasia
granted -
US 11821008
Liver targeting adeno-associated viral vectors
granted -
US 11739345
Methods of treating phenylketonuria
granted -
US 11690898
Adeno-associated virus Factor VIII vectors, associated viral particles and therapeutic formulations comprising the same
granted -
US 11590204
Use of C-type natriuretic peptide variants to treat skeletal dysplasia
granted -
US 11584780
Adeno-associated virus capsid proteins
granted -
US 11505790
Compositions of prokaryotic phenylalanine ammonia-lyase variants and methods of using compositions thereof
granted -
US 11406690
Adeno-associated virus factor VIII vectors
granted -
US 11384055
Glycolate oxidase inhibitors for the treatment of disease
granted -
US 11358932
N-(1-hydroxy-3-(pyrrolidinyl)propan-2-yl)pyrrolidine-3-carboxamide derivatives as glucosylceramide synthase inhibitors
granted -
US 11351231
Lysosomal targeting peptides and uses thereof
granted -
US 11345904
Targeted therapeutic lysosomal enzyme fusion proteins, associated formulations and uses thereof
granted -
US 11254725
Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof
granted -
US 11229687
TPP-1 formulations and methods for treating CLN2 disease
granted -
US 11202819
Use of C-type natriuretic peptide variants to treat osteoarthritis
granted -
US 11040088
Delivery of therapeutic compounds to the brain and other tissues
granted -
US 10934534
Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof
granted -
US 10851058
Histone deacetylase inhibitors
granted